Expanding the toolbox of organic chemists: directed evolution of P450 monooxygenases as catalysts in regio- and stereoselective oxidative hydroxylation.
暂无分享,去创建一个
[1] V. Urlacher,et al. Cluster Screening: An Effective Approach for Probing the Substrate Space of Uncharacterized Cytochrome P450s , 2013, Chembiochem : a European journal of chemical biology.
[2] Manfred T. Reetz,et al. Directed Evolution of an Enantioselective Enzyme through Combinatorial Multiple-Cassette Mutagenesis. , 2001, Angewandte Chemie.
[3] D. Sherman,et al. Selective oxidation of carbolide C–H bonds by an engineered macrolide P450 mono-oxygenase , 2009, Proceedings of the National Academy of Sciences.
[4] Frank Schulz,et al. Minimally invasive mutagenesis gives rise to a biosynthetic polyketide library. , 2012, Angewandte Chemie.
[5] Frances H Arnold,et al. Chemo-enzymatic fluorination of unactivated organic compounds. , 2009, Nature chemical biology.
[6] L. Narhi,et al. Characterization of a catalytically self-sufficient 119,000-dalton cytochrome P-450 monooxygenase induced by barbiturates in Bacillus megaterium. , 1986, The Journal of biological chemistry.
[7] Adrian J Mulholland,et al. Compound I reactivity defines alkene oxidation selectivity in cytochrome P450cam. , 2010, The journal of physical chemistry. B.
[8] Y Fujii-Kuriyama,et al. Site-directed mutageneses of rat liver cytochrome P-450d: catalytic activities toward benzphetamine and 7-ethoxycoumarin. , 1989, Biochemistry.
[9] Joelle N. Pelletier,et al. Expanding the organic toolbox: a guide to integrating biocatalysis in synthesis. , 2012, Chemical Society reviews.
[10] Jizhen Zhang,et al. Catalytic oxidation of light alkanes (C1-C4) by heteropoly compounds. , 2014, Chemical reviews.
[11] B. Trost,et al. Asymmetric transition-metal-catalyzed allylic alkylations: applications in total synthesis. , 2003, Chemical reviews.
[12] J. Pleiss,et al. Conservation analysis of class‐specific positions in cytochrome P450 monooxygenases: Functional and structural relevance , 2014, Proteins.
[13] S. Bell,et al. Selective aliphatic carbon-hydrogen bond activation of protected alcohol substrates by cytochrome P450 enzymes. , 2014, Organic & biomolecular chemistry.
[14] Vlada B Urlacher,et al. Screening of a minimal enriched P450 BM3 mutant library for hydroxylation of cyclic and acyclic alkanes. , 2011, Chemical communications.
[15] K. Auclair,et al. Controlling substrate specificity and product regio- and stereo-selectivities of P450 enzymes without mutagenesis. , 2014, Bioorganic & medicinal chemistry.
[16] Joseph P. Adams,et al. Asymmetric epoxidation of alkenes and benzylic hydroxylation with P450tol monooxygenase from Rhodococcus coprophilus TC-2. , 2014, Chemical communications.
[17] P. R. Montellano. Hydrocarbon hydroxylation by cytochrome P450 enzymes. , 2010 .
[18] U. Schwaneberg,et al. First steps towards a Zn/Co(III)sep-driven P450 BM3 reactor , 2011, Applied Microbiology and Biotechnology.
[19] Manfred T Reetz,et al. Regio- and stereoselectivity of P450-catalysed hydroxylation of steroids controlled by laboratory evolution , 2011, Nature Chemistry.
[20] V. Urlacher,et al. A novel P450-based biocatalyst for the selective production of chiral 2-alkanols. , 2014, Chemical Communications.
[21] S. Bell,et al. A Highly Active Single‐Mutation Variant of P450BM3 (CYP102A1) , 2009, Chembiochem : a European journal of chemical biology.
[22] S. Bell,et al. P450(BM3) (CYP102A1): connecting the dots. , 2012, Chemical Society reviews.
[23] Jullien Drone,et al. A regioselective biocatalyst for alkane activation under mild conditions. , 2011, Angewandte Chemie.
[24] K. R. Marshall,et al. P450 BM3: the very model of a modern flavocytochrome. , 2002, Trends in biochemical sciences.
[25] V. Sieber,et al. Biocatalytic Synthesis of a Diketobornane as a Building Block for Bifunctional Camphor Derivatives , 2013 .
[26] M. Reetz,et al. Directed Evolution of an Enantioselective Enoate-Reductase: Testing the Utility of Iterative Saturation Mutagenesis , 2009 .
[27] Philip A. Romero,et al. Exploring protein fitness landscapes by directed evolution , 2009, Nature Reviews Molecular Cell Biology.
[28] I. Arends,et al. The taming of oxygen: biocatalytic oxyfunctionalisations. , 2014, Chemical communications.
[29] S. D. Beer,et al. Regio‐ and Stereoselective Hydroxylation of Optically Active α‐Ionone Enantiomers by Engineered Cytochrome P450 BM3 Mutants , 2012 .
[30] S. Laschat,et al. Selective allylic hydroxylation of acyclic terpenoids by CYP154E1 from Thermobifida fusca YX , 2014, Beilstein journal of organic chemistry.
[31] Kurt Faber,et al. Biotransformations in Organic Chemistry , 1992 .
[32] M. Reetz,et al. Biocatalysis in organic chemistry and biotechnology: past, present, and future. , 2013, Journal of the American Chemical Society.
[33] V. Urlacher,et al. Novel family members of CYP109 from Sorangium cellulosum So ce56 exhibit characteristic biochemical and biophysical properties , 2013, Biotechnology and applied biochemistry.
[34] M. Machius,et al. Pivotal role of water in the mechanism of P450BM-3. , 2001, Biochemistry.
[35] Manfred T Reetz,et al. Tuning a p450 enzyme for methane oxidation. , 2011, Angewandte Chemie.
[36] R. Agudo,et al. Stereo- and regioselectivity in the P450-catalyzed oxidative tandem difunctionalization of 1-methylcyclohexene , 2013 .
[37] R. Lonsdale,et al. CH-activating oxidative hydroxylation of 1-tetralones and related compounds with high regio- and stereoselectivity. , 2014, Chemical communications.
[38] Weng Lin Tang,et al. High-throughput method for determining the enantioselectivity of enzyme-catalyzed hydroxylations based on mass spectrometry. , 2010, Angewandte Chemie.
[39] S. S. Yu,et al. Regioselective hydroxylation of C(12)-C(15) fatty acids with fluorinated substituents by cytochrome P450 BM3. , 2013, Chemistry.
[40] Jeremy N. Harvey,et al. Inclusion of Dispersion Effects Significantly Improves Accuracy of Calculated Reaction Barriers for Cytochrome P450 Catalyzed Reactions , 2010 .
[41] G. Gilardi,et al. Identification of mutant Asp251Gly/Gln307His of cytochrome P450 BM3 for the generation of metabolites of diclofenac, ibuprofen and tolbutamide. , 2012, Chemistry.
[42] Bernhard Hauer,et al. An Efficient Route to Selective Bio‐oxidation Catalysts: an Iterative Approach Comprising Modeling, Diversification, and Screening, Based on CYP102A1 , 2011, Chembiochem : a European journal of chemical biology.
[43] J. Pietruszka,et al. Enantioselective allylic hydroxylation of ω-alkenoic acids and esters by P450 BM3 monooxygenase. , 2014, Angewandte Chemie.
[44] D. Zheng,et al. Regio- and stereoselective benzylic hydroxylation to synthesize chiral tetrahydroquinolin-4-ol and tetrahydro-1H-benzo[b]azepin-5-ol with Pseudomonas plecoglossicidas , 2014 .
[45] M. Reetz,et al. Directed evolution of cyclohexanone monooxygenases: enantioselective biocatalysts for the oxidation of prochiral thioethers. , 2004, Angewandte Chemie.
[46] Manfred T Reetz,et al. Laboratory evolution of stereoselective enzymes: a prolific source of catalysts for asymmetric reactions. , 2011, Angewandte Chemie.
[47] F. Arnold,et al. Combinatorial Alanine Substitution Enables Rapid Optimization of Cytochrome P450BM3 for Selective Hydroxylation of Large Substrates , 2010, Chembiochem : a European journal of chemical biology.
[48] H. Pellissier,et al. CHEMICAL AND BIOCHEMICAL HYDROXYLATIONS OF STEROIDS. A REVIEW , 2001 .
[49] Manfred T. Reetz,et al. Creation of Enantioselective Biocatalysts for Organic Chemistry by In Vitro Evolution , 1997 .
[50] Vlada B Urlacher,et al. Light‐driven biocatalysis with cytochrome P450 peroxygenases , 2013, Biotechnology and applied biochemistry.
[51] Christian Wandrey,et al. Industrial Biotransformations: LIESE: INDUSTRIAL BIOTRANSFORMATIONS O-BK , 2006 .
[52] Linda G. Otten,et al. Enzyme engineering for enantioselectivity: from trial-and-error to rational design? , 2010, Trends in biotechnology.
[53] Zhanglin Lin,et al. Semi‐rational engineering of cytochrome P450sca‐2 in a hybrid system for enhanced catalytic activity: Insights into the important role of electron transfer , 2013, Biotechnology and bioengineering.
[54] Jürgen Pleiss,et al. Multiple molecular dynamics simulations of human p450 monooxygenase CYP2C9: The molecular basis of substrate binding and regioselectivity toward warfarin , 2006, Proteins.
[55] L. Wong,et al. Protein engineering of Bacillus megaterium CYP102. The oxidation of polycyclic aromatic hydrocarbons. , 2001, European journal of biochemistry.
[56] Wei Li,et al. New α-Tetralonyl Glucosides from the Fruit of Juglans mandshurica , 2004 .
[57] Nicholas J. Turner,et al. Substrate promiscuity of cytochrome P450 RhF , 2013 .
[58] H. Bohets,et al. Recombinant Escherichia coli cells immobilized in Ca-alginate beads for metabolite production , 2009 .
[59] N. Vermeulen,et al. Evaluation of alkoxyresorufins as fluorescent substrates for high-throughput screening of cytochrome P450BM3 and site-directed mutants , 2005 .
[60] M. White. Adding Aliphatic C–H Bond Oxidations to Synthesis , 2012, Science.
[61] P. Baran,et al. If C-H bonds could talk: selective C-H bond oxidation. , 2011, Angewandte Chemie.
[62] Yong Wang,et al. P450 enzymes: their structure, reactivity, and selectivity-modeled by QM/MM calculations. , 2010, Chemical reviews.
[63] G. Sprenger,et al. Selective Catalytic Oxidation of CH Bonds with Molecular Oxygen , 2013 .
[64] Harry A. Stern,et al. Controlled Oxidation of Remote sp3 C–H Bonds in Artemisinin via P450 Catalysts with Fine-Tuned Regio- and Stereoselectivity , 2012, Journal of the American Chemical Society.
[65] J. Woodley,et al. Guidelines and Cost Analysis for Catalyst Production in Biocatalytic Processes , 2011 .
[66] Huilei Yu,et al. Unusually Broad Substrate Profile of Self‐Sufficient Cytochrome P450 Monooxygenase CYP116B4 from Labrenzia aggregata , 2014, Chembiochem : a European journal of chemical biology.
[67] X. Ribas,et al. The Iron(II) Complex [Fe(CF3SO3)2(mcp)] as a Convenient, Readily Available Catalyst for the Selective Oxidation of Methylenic Sites in Alkanes , 2014 .
[68] Zhi Li,et al. Engineering of p450pyr hydroxylase for the highly regio- and enantioselective subterminal hydroxylation of alkanes. , 2014, Angewandte Chemie.
[69] Yosephine Gumulya,et al. Many Pathways in Laboratory Evolution Can Lead to Improved Enzymes: How to Escape from Local Minima , 2012, Chembiochem : a European journal of chemical biology.
[70] F. Arnold,et al. Enantioselective alpha-hydroxylation of 2-arylacetic acid derivatives and buspirone catalyzed by engineered cytochrome P450 BM-3. , 2006, Journal of the American Chemical Society.
[71] David Taub,et al. The Total Synthesis of Steroids1 , 1952 .
[72] Manfred T. Reetz,et al. A GC-based method for high-throughput screening of enantioselective catalysts , 2001 .
[73] M. Reetz,et al. Light‐Driven Biocatalytic Oxidation and Reduction Reactions: Scope and Limitations , 2008, Chembiochem : a European journal of chemical biology.
[74] Karl H. Clodfelter,et al. Computational solvent mapping reveals the importance of local conformational changes for broad substrate specificity in mammalian cytochromes P450. , 2006, Biochemistry.
[75] Rudi Fasan,et al. Enhancing the Efficiency and Regioselectivity of P450 Oxidation Catalysts by Unnatural Amino Acid Mutagenesis , 2014, Chembiochem : a European journal of chemical biology.
[76] Bernhard Hauer,et al. New generation of biocatalysts for organic synthesis. , 2014, Angewandte Chemie.
[77] Gheorghe-Doru Roiban,et al. Cytochrome P450 catalyzed oxidative hydroxylation of achiral organic compounds with simultaneous creation of two chirality centers in a single C-H activation step. , 2014, Angewandte Chemie.
[78] T. Darden,et al. Altering the regiospecificity of androstenedione hydroxylase activity in P450s 2a-4/5 by a mutation of the residue at position 481. , 1995, Biochemistry.
[79] G. A. Berchtold,et al. Total synthesis of (-)-chorismic acid and (-)-shikimic acid , 1987 .
[80] M. Reetz,et al. Designer cells for stereocomplementary de novo enzymatic cascade reactions based on laboratory evolution. , 2013, Chemical communications.
[81] Jan Marienhagen,et al. Direct oxidation of cycloalkanes to cycloalkanones with oxygen in water. , 2013, Angewandte Chemie.
[82] Frank Hollmann,et al. Biocatalytic Redox Reactions for Organic Synthesis: Nonconventional Regeneration Methods , 2010 .
[83] J. Hogg. Steroids, the steroid community, and Upjohn in perspective: a profile of innovation , 1992, Steroids.
[84] S. Wijmenga,et al. Active site substitution A82W improves the regioselectivity of steroid hydroxylation by cytochrome P450 BM3 mutants as rationalized by spin relaxation nuclear magnetic resonance studies. , 2012, Biochemistry.
[85] Wayne M Patrick,et al. Strategies and computational tools for improving randomized protein libraries. , 2005, Biomolecular engineering.
[86] Frances H. Arnold,et al. Laboratory evolution of a soluble, self-sufficient, highly active alkane hydroxylase , 2002, Nature Biotechnology.
[87] Oliver May,et al. Application of designed enzymes in organic synthesis. , 2011, Chemical reviews.
[88] Nicholas J Turner,et al. Directed evolution of an amine oxidase possessing both broad substrate specificity and high enantioselectivity. , 2003, Angewandte Chemie.
[89] Matthias Dietrich,et al. Altering the regioselectivity of the subterminal fatty acid hydroxylase P450 BM-3 towards gamma- and delta-positions. , 2009, Journal of biotechnology.
[90] Nicholas J Turner,et al. Directed evolution drives the next generation of biocatalysts. , 2009, Nature chemical biology.
[91] Karlheinz Drauz,et al. Enzyme Catalysis in Organic Synthesis , 1995 .
[92] Rudi Fasan,et al. P450 fingerprinting method for rapid discovery of terpene hydroxylating P450 catalysts with diversified regioselectivity. , 2011, Journal of the American Chemical Society.
[93] A. Ilie,et al. P450-catalyzed regio- and stereoselective oxidative hydroxylation of disubstituted cyclohexanes: creation of three centers of chirality in a single CH-activation event , 2015 .
[94] S. Sligar,et al. Decreased substrate affinity upon alteration of the substrate‐docking region in cytochrome P450BM‐3 , 1997, FEBS letters.
[95] F Peter Guengerich,et al. Complex reactions catalyzed by cytochrome P450 enzymes. , 2007, Biochimica et biophysica acta.
[96] F. Arnold,et al. Enzymatic functionalization of carbon-hydrogen bonds. , 2011, Chemical Society reviews.
[97] R. Bernhardt,et al. Changing the Regioselectivity of a P450 from C15 to C11 Hydroxylation of Progesterone , 2012, Chembiochem : a European journal of chemical biology.
[98] Frances H Arnold,et al. Engineered alkane-hydroxylating cytochrome P450(BM3) exhibiting nativelike catalytic properties. , 2007, Angewandte Chemie.
[99] M. Machius,et al. Crystal structure of inhibitor-bound P450BM-3 reveals open conformation of substrate access channel. , 2008, Biochemistry.
[100] Manfred T Reetz,et al. The importance of additive and non-additive mutational effects in protein engineering. , 2013, Angewandte Chemie.
[101] D. Sherman,et al. Diversity of P450 enzymes in the biosynthesis of natural products. , 2012, Natural product reports.
[102] T. Poulos,et al. The structure of the cytochrome p450BM-3 haem domain complexed with the fatty acid substrate, palmitoleic acid , 1997, Nature Structural Biology.
[103] R. Fasan. Tuning P450 Enzymes as Oxidation Catalysts , 2012 .
[104] Lionel Cheruzel,et al. Regio- and stereoselective hydroxylation of 10-undecenoic acid with a light-driven P450 BM3 biocatalyst yielding a valuable synthon for natural product synthesis. , 2014, Bioorganic & medicinal chemistry.
[105] Frances H Arnold,et al. Regio- and enantioselective alkane hydroxylation with engineered cytochromes P450 BM-3. , 2003, Journal of the American Chemical Society.
[106] Huimin Zhao,et al. Inverting the enantioselectivity of P450pyr monooxygenase by directed evolution. , 2010, Chemical communications.
[107] N. Vermeulen,et al. A Single Active Site Mutation Inverts Stereoselectivity of 16‐Hydroxylation of Testosterone Catalyzed by Engineered Cytochrome P450 BM3 , 2012, Chembiochem : a European journal of chemical biology.
[108] David Baker,et al. A novel semi-biosynthetic route for artemisinin production using engineered substrate-promiscuous P450(BM3). , 2009, ACS chemical biology.
[109] V. Urlacher,et al. Regioselective hydroxylation of norisoprenoids by CYP109D1 from Sorangium cellulosum So ce56 , 2010, Applied Microbiology and Biotechnology.
[110] A. Munro,et al. Variations on a (t)heme--novel mechanisms, redox partners and catalytic functions in the cytochrome P450 superfamily. , 2007, Natural product reports.
[111] I. Antes,et al. Theoretical and Experimental Evaluation of a CYP106A2 Low Homology Model and Production of Mutants with Changed Activity and Selectivity of Hydroxylation , 2008, Chembiochem : a European journal of chemical biology.
[112] Gheorghe-Doru Roiban,et al. Achieving Regio‐ and Enantioselectivity of P450‐Catalyzed Oxidative CH Activation of Small Functionalized Molecules by Structure‐Guided Directed Evolution , 2012, Chembiochem : a European journal of chemical biology.
[113] Andreas Vogel,et al. Expanding the substrate scope of enzymes: combining mutations obtained by CASTing. , 2006, Chemistry.
[114] Manfred T Reetz,et al. A Method for High-Throughput Screening of Enantioselective Catalysts. , 1999, Angewandte Chemie.
[115] T. Poulos. Reversing enzyme specificity , 1989, Nature.
[116] N. Turner,et al. Cytochromes P450 as useful biocatalysts: addressing the limitations. , 2011, Chemical communications.
[117] P. Gannett,et al. The Use of Immobilized Cytochrome P4502C9 in PMMA-Based Plug Flow Bioreactors for the Production of Drug Metabolites , 2014, Applied Biochemistry and Biotechnology.
[118] Manfred T Reetz,et al. Iterative saturation mutagenesis (ISM) for rapid directed evolution of functional enzymes , 2007, Nature Protocols.
[119] Ulrich Schwaneberg,et al. Regioselective o-hydroxylation of monosubstituted benzenes by P450 BM3. , 2013, Angewandte Chemie.
[120] Nico P E Vermeulen,et al. Application of engineered cytochrome P450 mutants as biocatalysts for the synthesis of benzylic and aromatic metabolites of fenamic acid NSAIDs. , 2014, Bioorganic & medicinal chemistry.
[121] L. Wong,et al. Cytochrome P450 monooxygenases. , 1998, Current opinion in chemical biology.
[122] K. Drauz,et al. Enzyme Catalysis in Organic Synthesis: DRAUZ:ENZYME CAT.3VLS.3ED O-BK , 2012 .
[123] R D Schmid,et al. Rational evolution of a medium chain-specific cytochrome P-450 BM-3 variant. , 2001, Biochimica et biophysica acta.
[124] M. Honing,et al. Role of residue 87 in substrate selectivity and regioselectivity of drug-metabolizing cytochrome P450 CYP102A1 M11 , 2011, JBIC Journal of Biological Inorganic Chemistry.
[125] Davidr . Evans,et al. Substrate-directable chemical reactions , 1993 .
[126] Xing-Cong Li,et al. New α-Tetralone Galloylglucosides from the Fresh Pericarps of Juglans sigillata. , 2010, Helvetica chimica acta.
[127] T. Brück,et al. Production of Macrocyclic Sesqui‐ and Diterpenes in Heterologous Microbial Hosts: A Systems Approach to Harness Nature’s Molecular Diversity , 2014 .
[128] Son Quang Pham,et al. Evolving P450pyr hydroxylase for highly enantioselective hydroxylation at non-activated carbon atom. , 2012, Chemical communications.
[129] M. Sanford,et al. Controlling site selectivity in palladium-catalyzed C-H bond functionalization. , 2012, Accounts of chemical research.
[130] U. Schwaneberg,et al. Benzylic hydroxylation of aromatic compounds by P450 BM3 , 2013 .
[131] Andreas Schmid,et al. Whole-cell biocatalysis for selective and productive C-O functional group introduction and modification. , 2013, Chemical Society reviews.
[132] S. Bell,et al. Biotransformation of the sesquiterpene (+)-valencene by cytochrome P450cam and P450BM-3. , 2005, Organic & biomolecular chemistry.
[133] T. Ahn,et al. Regioselective hydroxylation of 17β-estradiol by mutants of CYP102A1 from Bacillus megaterium , 2014, Biotechnology Letters.
[134] Manfred T Reetz,et al. Iterative saturation mutagenesis: a powerful approach to engineer proteins by systematically simulating Darwinian evolution. , 2014, Methods in molecular biology.
[135] S. Imaoka,et al. Construction and engineering of a thermostable self-sufficient cytochrome P450. , 2009, Biochemical and biophysical research communications.